Mon, Jun 24, 2024
As part of the merger, Sun Pharma has acquired all outstanding ordinary shares of Taro other than the shares already held by it or its affiliates.
More >
Thu, May 23, 2024
The merger agreement between Israel-based Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders at an extraordinary general meeting and an ordinary class meeting on May 22, 2024, the drug major said in a statement.
Thu, Jan 18, 2024
On Thursday, Sun Pharma shares ended weaker by Rs 14.3, or 1.1 per cent, at Rs 1,299.3 apiece.
Mon, May 29, 2023
Sun Pharmaceutical Industries on Saturday said it has proposed to fully acquire Israel-based Taro Pharmaceutical Industries through a reverse triangular merger. How much Sun Pharma benefited from the deal? Know in this video.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
